Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Eugenia Vicky Asare"'
Autor:
William Kwesi Ghunney, Eugenia Vicky Asare, John Benaiah Ayete-Nyampong, Samuel Antwi Oppong, Mark Rodeghier, Michael R DeBaun, Edeghonghon Olayemi
Publikováno v:
Blood Advances.
HbSC disease is the second most frequent sickle cell disease (SCD) genotype after HbSS. Globally, approximately 55,000 newborns are delivered annually with HbSC disease, with the highest HbC gene frequency in West Africa. In Ghana, 40% of adults atte
Autor:
Eugenia Vicky Asare, Michael R. DeBaun, Edeghonghon Olayemi, Theodore Boafor, Samuel A. Oppong
Publikováno v:
Hematology Am Soc Hematol Educ Program
Pregnancy in women with sickle cell disease (SCD) is a life-threatening condition. In both high- and low-income countries, there is an 11-fold increased risk of maternal death and a 4-fold increased risk of perinatal death. We highlight the epidemiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75b26a2d3e5d839b32b5fccce8634bf4
https://europepmc.org/articles/PMC9821602/
https://europepmc.org/articles/PMC9821602/
Autor:
William T Zempsky, Mary Yanaros, Mohammed Sayeem, Donna Boruchov, Connie M Piccone, Deepa Manwani, Crawford Strunk, Immacolata Tartaglione, Raffaella Colombatti, Sophia Akatue, Bianca Oteng, Ahmed Owda, Rose Bamfo, Samuel Wilson, Angela Rivers, Fatimah Farooq, Rebekah Urbonya, Gifty Dankwah Boatemaa, Sudha Rao, Baba Inusa, Charles Antwi-Boasiako, Catherine Segbefia, Fredericka Sey, Biree Andemariam, Eugenia Vicky Asare, Andrew D Campbell
Objectives Sickle Cell Disease (SCD) is a genetic blood disorder affecting over 1 million people globally. The aim of this analysis is to explore the pain burden of patients with SCD in two countries: the United States and Ghana. Methods The Consorti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58350059a74d1ee6f93c6e9f59bc1a24
http://hdl.handle.net/11591/465294
http://hdl.handle.net/11591/465294
Autor:
Charles Hayfron-Benjamin, Eugenia Vicky Asare, Theodore Boafor, Michael R. DeBaun, Adetola A. Kassim, Mark Rodeghier, Samuel A. Oppong, Yvonne Dei-Adomakoh, Latif Musah, Enoch Mensah, Titus Beyuo, Edeghonghon Olayemi
Publikováno v:
American Journal of Hematology. 96
Autor:
Charles F, Hayfron-Benjamin, Eugenia Vicky, Asare, Theodore, Boafor, Edeghonghon, Olayemi, Yvonne, Dei-Adomakoh, Latif, Musah, Enoch, Mensah, Titus, Beyuo, Adetola A, Kassim, Mark, Rodeghier, Michael R, DeBaun, Samuel A, Oppong
Publikováno v:
American journal of hematologyREFERENCES. 96(8)
Autor:
Charles Antwi-Boasiako, Eugenia Vicky Asare, Donna Boruchov, Connie M. Piccone, Fatimah Farooq, Laura Sainati, Silverio Perrotta, Biree Andemariam, William T. Zempsky, Raffaella Colombatti, Immacolata Tartaglione, Rebekah Urbonya, Catherine I. Segbefia, Andrew D. Campbell, Deepa Manwani, Fredericka Sey, Gifty Dankwah Boatemaa, Sudha Rao, Crawford John Strunk, Baba Inusa, Angela Rivers
Publikováno v:
J Racial Ethn Health Disparities
Millions are affected by Sickle Cell Disease (SCD) worldwide with the greatest burden in sub-Saharan Africa. While its origin lies historically within the malaria belt, ongoing changes in migration patterns have shifted the burden of disease resultin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d124b5bf5dd138c01b556aad10638b01
http://hdl.handle.net/11591/430151
http://hdl.handle.net/11591/430151
Autor:
Ashya Smith, Samuel Wilson, William T. Zempsky, Donna Boruchov, Gifty Dankwah Boatemaa, Silverio Perrotta, Catherine I. Segbefia, Sudha Rao, Laura Sainati, Angela Rivers, Ivy Ekem, Connie M. Piccone, Fredericka Sey, Andrew D. Campbell, Charles Antwi-Boasiako, Eugenia Vicky Asare, Immacolata Tartaglione, Crawford John Strunk, Esther Kim, Raffaella Colombatti, Rebekah Urbonya, Fatimah Farooq, Baba Inusa, Haikel Haile, Biree Andemariam, Deepa Manwani
Publikováno v:
Blood Cells Mol Dis
Background: Sickle cell disease (SCD) is characterized by frequent, unpredictable pain episodes and other vaso-occlusive crises (VOCs) leading to significant healthcare utilization. VOC frequency is often an endpoint in clinical trials investigating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::457154d98a0b6fca1a8d22bdf15686d9
http://hdl.handle.net/11591/458237
http://hdl.handle.net/11591/458237
Autor:
Donna Boruchov, Charles Antwi-Boasiako, Eugenia Vicky Asare, Fitz Tavernier, Fredericka Sey, Andrew D. Campbell, Sudha Rao, Sophia Akatue, Ahmed Owda, Gifty Dankwah Boatemaa, Connie M. Piccone, Baba Inusa, Rose Bamfo, Immacolata Tartaglione, Samuel Wilson, Crawford John Strunk, Deepa Manwani, Catherine I. Segbefia, William T. Zempsky, Fatimah Farooq, Silverio Perrotta, Biree Andemariam, Raffaella Colombatti, Rebekah Urbonya, Bianca Oteng
Publikováno v:
Blood cells, moleculesdiseases. 88
Pain is a hallmark of Sickle Cell Disease (SCD) affecting patients throughout their life; the first pain crisis may occur at any age and is often the first presentation of the disease. Universal newborn screening identifies children with SCD at birth
Autor:
Deepa Manwani, William T. Zempsky, Sudha Rao, Baba Inusa, Biree Andemariam, Andrew D. Campbell, Charles Antwi-Boasiako, Eugenia Vicky Asare, Angela Rivers, Donna Boruchov, Silverio Perrotta, Laura Sainati, Connie M. Piccone, Rebekah Urbonya, Immacolata Tartaglione, Ivy Ekem, Fredericka Sey, Crawford John Strunk, Catherine I. Segbefia, Gifty Dankwah Boatemaa, Fatimah Farooq, Raffaella Colombatti, Samuel Wilson
Publikováno v:
Ann Hematol
Vasculopathy is a hallmark of sickle cell disease ultimately resulting in chronic end organ damage. Leg ulcer is one of its sequelae, occurring in ~ 5–10% of adult sickle cell patients. The majority of leg ulcer publications to date have emanated f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f8ef2935ccae7c1020529b61f36717
http://hdl.handle.net/11577/3353236
http://hdl.handle.net/11577/3353236
Autor:
Adetola A. Kassim, Samuel A. Oppong, John Ayete-Nyampong, Yvonne Adomakoh, Eugenia Vicky Asare, Mark Rodeghier, William Kwesi Ghunney, Michael R. DeBaun, Edeghonghon Olayemi
Publikováno v:
Blood. 138:487-487
Introduction : Sickle cell disease (SCD), HbSC, is the second most frequent hemoglobinopathy after HbSS. Worldwide, an estimated 54,736 babies are delivered annually with HbSC disease, with the highest HbC gene frequency in West Africa (Piel et al.20